Characteristics of responders to atropine 0.01% as treatment in Asian myopic children
Abstract Recently, low-concentration atropine (0.01%) has gained increased attention in controlling myopia progression with satisfying effects and minimal side effects. However, studies concerning responders to 0.01% atropine are limited. This retrospective observational cohort study aimed to determ...
Main Authors: | Lung-Chi Lee, Meng-Wei Hsieh, Yi-Hao Chen, Po-Liang Chen, Ke-Hung Chien |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-10978-3 |
Similar Items
-
Efficacy of 0.01% atropine in myopic children of different ages
by: Lan Hu, et al.
Published: (2023-03-01) -
Role of 0.01% atropine in high myopic children of Moradabad, India (RAMCOM Study)
by: Pradeep Agarwal, et al.
Published: (2022-01-01) -
Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis
by: Hou-Ren Tsai, et al.
Published: (2021-08-01) -
Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine
by: Qi Tan, et al.
Published: (2023-06-01) -
Effect of low-concentration atropine (0.01%) eye drops on higher-order aberrations in myopic children
by: Jitendra Jethani, et al.
Published: (2021-01-01)